Global X - Genomics & Biotechnology ETF (GNOM) Expected Move
Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.
Global X - Genomics & Biotechnology ETF (GNOM) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $51.9M, listed on NASDAQ, carrying a beta of 1.57 to the broader market. The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. public since 2019-04-10.
Snapshot as of May 15, 2026.
- Spot Price
- $44.39
- Expected Move
- 12.8%
- Implied High
- $50.08
- Implied Low
- $38.70
- Front DTE
- 34 days
As of May 15, 2026, Global X - Genomics & Biotechnology ETF (GNOM) has an expected move of 12.82%, a one-standard-deviation implied price range of roughly $38.70 to $50.08 from the current $44.39. Expected move is derived from at-the-money straddle pricing and represents the market's pricing of a ±1σ move. Roughly 68% of outcomes should fall within this range under lognormal assumptions, though empirical markets have fatter tails.
GNOM Strategy Sizing to the Expected Move
With Global X - Genomics & Biotechnology ETF pricing an expected move of 12.82% from $44.39, risk-defined strategies sized to the implied range structurally target the modal outcome distribution. Iron condors with wings at the ±1σ expected move boundaries collect premium against the ~68% probability that spot stays inside the range under lognormal assumptions; strangles set wider at ±1.5σ or ±2σ target the tails but pay smaller per-trade premium. Long-vol structures (long straddles, ratio backspreads) profit when realized move exceeds the implied move, the inverse trade: they bet against the lognormal assumption itself, capitalizing on the empirically fatter equity-return tails.
Learn how expected move is reported and how to read the data →
Per-expiration expected move for GNOM derived from ATM implied volatility at each listed expiration. Implied high/low bounds are computed as $44.39 × (1 ± expected move %). One standard-deviation range under lognormal assumptions, roughly 68% of outcomes fall inside.
| Expiration | DTE | ATM IV | Expected Move | Implied High | Implied Low |
|---|---|---|---|---|---|
| Jun 18, 2026 | 34 | 44.7% | 13.6% | $50.45 | $38.33 |
| Jul 17, 2026 | 63 | 43.0% | 17.9% | $52.32 | $36.46 |
| Aug 21, 2026 | 98 | 39.7% | 20.6% | $53.52 | $35.26 |
| Nov 20, 2026 | 189 | 33.7% | 24.3% | $55.15 | $33.63 |
Frequently asked GNOM expected move questions
- What is the current GNOM expected move?
- As of May 15, 2026, Global X - Genomics & Biotechnology ETF (GNOM) has an expected move of 12.82% over the next 34 days, implying a one-standard-deviation price range of $38.70 to $50.08 from the current $44.39. The expected move is derived from at-the-money straddle pricing and represents the market consensus for a ±1σ price move.
- What does the GNOM expected move mean for traders?
- Roughly 68% of outcomes should fall within ±1 expected move and 95% within ±2 under lognormal assumptions, though equity returns have empirically fatter tails than log-normal predicts. Strategies sized to the expected move (iron condors at ±1σ, strangles at ±1.5σ) target the typical outcome distribution; strategies that profit from tail moves (long-vol structures, ratio backspreads) target the tails the lognormal model under-prices.
- How is GNOM expected move calculated?
- The expected move displayed here is derived from at-the-money implied volatility scaled to the chosen tenor: expected move % is approximately ATM IV times sqrt(T / 365), where T is days to expiration. An equivalent straddle-based form: the ATM straddle (call + put at the same strike) is roughly sqrt(2/pi) times spot times IV times sqrt(T/365), so the implied one-standard-deviation move is approximately 1.25 times ATM straddle divided by spot. The two formulations agree once the sqrt(2/pi) constant is reconciled.